Literature DB >> 27190172

Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis.

Larry K Kociolek1,2, Maria Bovee3, Donna Carter4, Jody D Ciolino5, Rupal Patel6, Anna O'Donnell3, Angela H Rupp3, Xiaotian Zheng4,7, Stanford T Shulman1,2, Sameer J Patel1,2.   

Abstract

BACKGROUND.: Although Clostridium difficile infections (CDIs) are increasingly diagnosed in children, many children diagnosed with CDI lack classic risk factors. Frequent use of highly sensitive tcdB polymerase chain reaction (PCR) testing in low-risk patients leads to CDI misdiagnosis and unnecessary CDI antibiotic use in children with C difficile carriage. METHODS.: For this quasi-experimental study, we developed and implemented an educational intervention (EI) to inform healthcare providers (HCPs) about tcdB PCR test limitations. We provided HCP didactic education and built an electronic notification into the tcdB PCR test order that describes scenarios in which carriage is more likely than CDI. Segmented regression analysis assessed changes in level (ie, overall rates) and trend of C difficile testing rate ([TR] number of tests performed per 1000 patient encounters) and test positivity rate ([PR] number of positive tests per 1000 patient encounters) between the pre- (August 2009-August 2013) and postintervention (February 2014-July 2015) periods. RESULTS.: Hospital-wide, absolute TR reduction was 0.71 (P[level] = .0067; P[trend] = .0042) and absolute PR reduction was 0.14 (P[level] = .22; P[trend] = .018). In the outpatient setting, absolute TR reduction was 0.30 (P[level] = .0015; P[trend] < .001) and absolute PR reduction was 0.09 (P[level] = .0069; P[trend] = .046). The incidence density of healthcare facility-associated CDI did not significantly change after the EI. The EI was associated with avoidance of 574 tests and 113 positive tests (and subsequent antibiotic courses) during the postintervention period, which saved approximately $250 000 in patient charges related to CDI testing and treatment. CONCLUSIONS.: Healthcare provider education can cost-effectively reduce the frequency of C difficile testing and CDI misdiagnosis by improving test utilization among low-risk children.
© The Author 2016. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Clostridium difficile; colonization; microbiology; pediatric; testing.

Mesh:

Year:  2017        PMID: 27190172      PMCID: PMC5907876          DOI: 10.1093/jpids/piw027

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  18 in total

1.  National variability in surveillance, testing, and infection prevention for Clostridium difficile infection in pediatric populations.

Authors:  Larry K Kociolek; Thomas J Sandora
Journal:  Am J Infect Control       Date:  2013-06-19       Impact factor: 2.918

2.  Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions.

Authors:  Larry K Kociolek; Sameer J Patel; Xiaotian Zheng; Kathleen M Todd; Stanford T Shulman; Dale N Gerding
Journal:  Pediatr Infect Dis J       Date:  2016-02       Impact factor: 2.129

3.  High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients.

Authors:  Samuel R Dominguez; Susan A Dolan; Kelly West; Raymund B Dantes; Erin Epson; Deborah Friedman; Cynthia A Littlehorn; Lesley E Arms; Karen Walton; Ellen Servetar; Daniel N Frank; Cassandra V Kotter; Elaine Dowell; Carolyn V Gould; Joanne M Hilden; James K Todd
Journal:  Clin Infect Dis       Date:  2014-04-29       Impact factor: 9.079

Review 4.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.

Authors:  Erik R Dubberke; Zhuolin Han; Linda Bobo; Tiffany Hink; Brenda Lawrence; Susan Copper; Joan Hoppe-Bauer; Carey-Ann D Burnham; William Michael Dunne
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

6.  Recommendations for surveillance of Clostridium difficile-associated disease.

Authors:  L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-25       Impact factor: 3.254

7.  Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea.

Authors:  Lance R Peterson; Rebecca U Manson; Suzanne M Paule; Donna M Hacek; Ari Robicsek; Richard B Thomson; Karen L Kaul
Journal:  Clin Infect Dis       Date:  2007-09-25       Impact factor: 9.079

8.  Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Authors:  Suchitra K Hourigan; Sankar R Chirumamilla; Tracy Ross; Jonathan E Golub; Shervin Rabizadeh; Shehzad A Saeed; Charles O Elson; Ciaran P Kelly; Karen C Carroll; Maria Oliva-Hemker; Cynthia Sears
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

9.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

10.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.

Authors:  Timothy D Planche; Kerrie A Davies; Pietro G Coen; John M Finney; Irene M Monahan; Kirsti A Morris; Lily O'Connor; Sarah J Oakley; Cassie F Pope; Mike W Wren; Nandini P Shetty; Derrick W Crook; Mark H Wilcox
Journal:  Lancet Infect Dis       Date:  2013-09-03       Impact factor: 25.071

View more
  4 in total

1.  Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.

Authors:  Larry K Kociolek; Preeta K Kutty; Philip M Polgreen; Susan E Beekmann
Journal:  Infect Control Hosp Epidemiol       Date:  2019-02-15       Impact factor: 3.254

2.  Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics.

Authors:  Larry K Kociolek
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

Review 3.  Implementation of Rapid Molecular Infectious Disease Diagnostics: the Role of Diagnostic and Antimicrobial Stewardship.

Authors:  Kevin Messacar; Sarah K Parker; James K Todd; Samuel R Dominguez
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

Review 4.  Advances in the diagnosis and treatment of Clostridium difficile infections.

Authors:  Zhong Peng; Lifen Ling; Charles W Stratton; Chunhui Li; Christopher R Polage; Bin Wu; Yi-Wei Tang
Journal:  Emerg Microbes Infect       Date:  2018-02-07       Impact factor: 7.163

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.